143 related articles for article (PubMed ID: 3284451)
1. [New inotropic drugs in chronic cardiac insufficiency: progress or wrong track].
Asseman P; Pruvost P; Lesenne M; Adnet P; Leroy F; Vigne JM; Delvallez L; Lacroix D; Thery C
Ann Cardiol Angeiol (Paris); 1988 Mar; 37(3):153-61. PubMed ID: 3284451
[TBL] [Abstract][Full Text] [Related]
2. Inotropic therapy for heart failure: an evidence-based approach.
Felker GM; O'Connor CM
Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
[TBL] [Abstract][Full Text] [Related]
3. Vasodilators and inotropic agents in the treatment of congestive heart failure.
Francis GS
Semin Nephrol; 1994 Sep; 14(5):464-78. PubMed ID: 7997651
[TBL] [Abstract][Full Text] [Related]
4. New inotropic-vasodilating drugs in acute and chronic heart failure.
Goenen MJ
Ann Med Interne (Paris); 1986; 137(3):229-34. PubMed ID: 3767191
[TBL] [Abstract][Full Text] [Related]
5. Nonglycoside inotropes in congestive heart failure. Are they beneficial or harmful?
Chatterjee K; Wolfe CL; DeMarco T
Cardiol Clin; 1994 Feb; 12(1):63-72. PubMed ID: 8181026
[TBL] [Abstract][Full Text] [Related]
6. Inotropic therapy is unsuccessful: wrong conceptual target or wrong therapeutic tools?
Rapezzi C; Perugini E; Santi M; Bracchetti G; Branzi A
Ital Heart J; 2003 May; 4 Suppl 2():22S-26S. PubMed ID: 14635366
[TBL] [Abstract][Full Text] [Related]
7. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
Erdmann E; Schwinger R; Böhm M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
[TBL] [Abstract][Full Text] [Related]
8. Survival in congestive heart failure during treatment with drugs with positive inotropic actions.
Packer M; Leier CV
Circulation; 1987 May; 75(5 Pt 2):IV55-63. PubMed ID: 3552303
[TBL] [Abstract][Full Text] [Related]
9. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
10. Management of congestive heart failure: is the role of positive inotropic therapy fading?
Futterman LG; Lemberg L
Am J Crit Care; 1996 Nov; 5(6):455-60. PubMed ID: 8922162
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic management of heart failure: positive inotropic agents.
Cross JA
Crit Care Nurs Clin North Am; 1993 Dec; 5(4):589-97. PubMed ID: 8297549
[TBL] [Abstract][Full Text] [Related]
13. [Inotropic agents].
Yasumura Y
Nihon Rinsho; 2006 May; 64(5):927-33. PubMed ID: 16689376
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the enoximone clinical trials program.
Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
[TBL] [Abstract][Full Text] [Related]
15. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
[TBL] [Abstract][Full Text] [Related]
16. Evolving concepts in the treatment of heart failure: should new inotropic agents carry promise or paranoia?
Young JB
Pharmacotherapy; 1996; 16(2 Pt 2):78S-84S. PubMed ID: 8668609
[TBL] [Abstract][Full Text] [Related]
17. [Inotropic drugs in treatment of heart failure--advantages and adverse reactions].
Witkowska M
Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):936-40. PubMed ID: 1300581
[TBL] [Abstract][Full Text] [Related]
18. [Push of inotropic drugs in the treatment of refractory chronic cardiac insufficiency].
Martínez Martínez JA; Salvati A; Suárez LD
Medicina (B Aires); 1986; 46(3):363-4. PubMed ID: 3574096
[No Abstract] [Full Text] [Related]
19. Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure.
Perrone SV; Kaplinsky EJ
Int J Cardiol; 2005 Sep; 103(3):248-55. PubMed ID: 16098385
[TBL] [Abstract][Full Text] [Related]
20. [New aspects for therapy of chronic heart failure with positive inotropic substances].
Erdmann E
Verh Dtsch Ges Inn Med; 1991; 97():178-84. PubMed ID: 1808882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
